Testing effectiveness (Phase 2)UnknownNCT01960829
What this trial is testing
Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study
Who this might be right for
MelanomaTOR Serine-Threonine KinasesNeoplasm Metastasis
Peking University Cancer Hospital & Institute 60